Interaction between drug Ukrain and Simvastatin in vitro studies

Autor

  • Magdalena Izdebska Department of Toxicology, Medical University of Lublin, Poland Autor
  • Dorota Natorska-Chomicka Department of Toxicology, Medical University of Lublin, Poland Autor
  • Ewa Jagiełło-Wójtowicz Department of Toxicology, Medical University of Lublin, Poland Autor

DOI:

https://doi.org/10.12923/j.2084-980X/25.1/a.04

Słowa kluczowe:

Ukrain, simvastatin, LDH, MTT, in vitro studies

Abstrakt

The aim of this study was to investigate the interaction between the drugs Ukrain and Simvastatin in vitro studies. The research was conducted on green monkey kidney cells (GMK). The experiment used the drug Ukrain (at concentrations of 50 μmol/l and 150 μmol/l), the drug Simvastatin (at concentrations of 100 μmol/l and 300 μmol/l), and the combination of these two drugs in the ratio of 1:1, 1:3 and 3:1. The cytotoxicity of both drugs were evaluated using a Cytotoxicity Detection Kit (LDH), while cell viability was determined using the MTT assay (based on the MTT assay protocol INVITTOX n°17, ECVAM), after 6, 12 and 24 h incubation with the tested drugs. Cytotoxicity of drug Ukrain (50 μmol/l) and Simvastatin (100 μmol/l) alone was observed after 6 h incubation of GMK cells with both drugs., while, Ukrain in combination with Simvastatin (300 μmol/l) showed cytotoxicity only after 12 h of incubation. However, cytotoxicity of the drug Ukrain (150 μmol/l), together with Simvastatin (100 μmol/l) was observed after 6 and 12 h incubation with GMK cells. The greatest inhibition growth of green monkey kidney cells was noted after 24 h incubation with all concentrations of these drugs.

Bibliografia

1. Adam O. and Laufs U.: Antioxidative effects of statins. Arch. Toxicol., 82, 885, 2008.

2. Cheng G. et al.: Apoptosis induced by simvastatin in rat vascular smooth muscle cell through Ca2+-calpain and caspase-3 dependent pathways. Pharmacol. Res., 48, 571, 2003.

3. Graaf M.R. et al.: Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer. Cancer Treat. Rev., 30, 609, 2004.

4. Habermehl D. et al.: Pro-apoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. BMC Cancer, 6, 14, 2006.

5. Jagiełło-Wojtowicz E, Kleinrok Z. and Urbanska E.M.: Ukrain (NSC¬-631570) in experimental and clinical studies: a review. Drugs Exptl. Clin. Res., 24, 213, 1998.

6. Kassimatis T.I. and Konstantinopoulos P.A.: The role of statins in chronic kidney disease (CKD): Friend or foe?. Pharmacol. Ther., 122, 312, 2009.

7. Korolenko T.A. et al.: Macrophage stimulation and anti-tumour effect of Ukrain. Drugs Exptl. Clin. Res., 24, 253, 1998.

8. Koshelnick Y. et al.: Ukrain (NSC-631570) inhibits angiogenic differentiation of human endothelial cells in vitro. 17th Internat. Cancer Congress, Rio de Janeiro, 24-28 August, 91, 1998.

9. Liepins A. et al.: Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570). Drugs Exptl. Clin. Res., 22, 73, 1996.

10. Liu H. et al.: Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression. Cancer Chemother. Pharmacol, 63, 997, 2009.

11. Mach T.: Statyny a ryzyko uszkodzenia wątroby. Przegl. Gastroenterol., 2, 111, 2007.

12. Merx M.W. and Weber C.: Benefits of statins beyond lipid lowering. Drug Discov. Today Dis. Mech., 5, 325, 2008.

13. Nowicky J.W., Hiesmayr W.and Liepins A.: Influence of Ukrain on DNA, RNA and protein synthesis in malignant cells. Drugs Exptl. Clin. Res., 22, 81, 1996.

14. Nowicky J.W., Hiesmayr W. and Liepins A.: Influence of Ukrain on immunological blood parameters in vitro and in vivo. Drugs Exptl. Clin. Res., 22, 163, 1996.

15. Roublevskaia I.N. et al.: Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain. Drugs Exptl. Clin. Res., 26, 141, 2000.

16. Seeger H. Wallwiener D. and Mueck A.O.: Statins can inhibit proliferation of human breast cancer cells in vitro. Exp. Clin. Endocrinol. Diabetes, 111, 47, 2003.

17. Sławińska A. and Kandefer-Szerszeń M.: Właściwości przeciwnowotworowe statyn. Postepy Hig. Med. Dosw., 62, 393, 2008.

18. Uglyanitsa K.N. et al.: Ukrain: A novel anti-tumour drug. Drugs Exptl. Clin. Res., 26, 341, 2000.

Opublikowane

2012-03-30